Gene · 3977
Papers2,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicles in tumorigenesis, metastasis, chemotherapy resistance and intercellular communication in osteosarcoma. | Bioengineered | 2023 | 37377390 | PubTator, text mining | PubMed |
| NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances. | Pharmaceuticals (Basel) | 2023 | 37375731 | PubTator, text mining | PubMed |
| Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours. | Int J Environ Res Public Health | 2023 | 37372675 | PubTator, text mining | PubMed |
| Controlled Attenuation Parameter Is Associated with a Distinct Systemic Inflammatory Milieu after Clearance of HCV Infection. | Biomedicines | 2023 | 37371624 | PubTator, text mining | PubMed |
| Identification of Novel Diagnostic and Prognostic Gene Signature Biomarkers for Breast Cancer Using Artificial Intelligence and Machine Learning Assisted Transcriptomics Analysis. | Cancers (Basel) | 2023 | 37370847 | PubTator, text mining | PubMed |
| Dynamic heterogeneity of colorectal cancer during progression revealed clinical risk-associated cell types and regulations in single-cell resolution and spatial context. | Gastroenterol Rep (Oxf) | 2023 | 37360193 | PubTator, text mining | PubMed |
| Role and mechanism of leukemia inhibitory factor receptor in cervical cancer invasion and metastasis. | J Int Med Res | 2023 | 37357760 | PubTator, text mining | PubMed |
| Mechanism of sorafenib resistance associated with ferroptosis in HCC. | Front Pharmacol | 2023 | 37351514 | PubTator, text mining | PubMed |
| Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma. | Cancers (Basel) | 2023 | 37345159 | PubTator, text mining | PubMed |
| Re-Evaluating the Role of PTHrP in Breast Cancer. | Cancers (Basel) | 2023 | 37345007 | PubTator, text mining | PubMed |
| Characterization of HZ0412a, a novel potent humanized anti-IL-6 receptor antibody that blocks IL-6R binding to gp130. | Antib Ther | 2023 | 37324549 | PubTator, text mining | PubMed |
| Oncostatin-M and OSM-Receptor Feed-Forward Activation of MAPK Induces Separable Stem-like and Mesenchymal Programs. | Mol Cancer Res | 2023 | 37310811 | PubTator, text mining | PubMed |
| Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells. | Environ Health Perspect | 2023 | 37307168 | PubTator, text mining | PubMed |
| Postpartum depression: aetiology, pathogenesis and the role of nutrients and dietary supplements in prevention and management. | Saudi Pharm J | 2023 | 37304359 | PubTator, text mining | PubMed |
| HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies. | Cancers (Basel) | 2023 | 37296866 | PubTator, text mining | PubMed |
| Paediatric survivors beyond infancy with Stüve-Wiedemann syndrome - A case series from the West Midlands, UK. | Eur J Med Genet | 2023 | 37295610 | PubTator, text mining | PubMed |
| A single cell transcriptomic fingerprint of stressed premature, imbalanced differentiation of embryonic stem cells. | bioRxiv | 2023 | 37292812 | PubTator, text mining | PubMed |
| Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations. | Front Cell Dev Biol | 2023 | 37287455 | PubTator, text mining | PubMed |
| Herpes Simplex Virus 1 MicroRNAs: An Update. | Intervirology | 2023 | 37285807 | PubTator, text mining | PubMed |
| Neuronal chemokines: new insights into neuronal communication after injury. | Neural Regen Res | 2023 | 37282457 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3977/papers?page=18